184 related articles for article (PubMed ID: 27126508)
1. A first-in-class and a fished out anticancer platinum compound: cis-[PtCl2(NH3)2] and cis-[PtI2(NH3)2] compared for their reactivity towards DNA model systems.
Musumeci D; Platella C; Riccardi C; Merlino A; Marzo T; Massai L; Messori L; Montesarchio D
Dalton Trans; 2016 May; 45(20):8587-600. PubMed ID: 27126508
[TBL] [Abstract][Full Text] [Related]
2. Reactions of cisplatin and cis-[PtI
Tolbatov I; Marzo T; Cirri D; Gabbiani C; Coletti C; Marrone A; Paciotti R; Messori L; Re N
J Inorg Biochem; 2020 Aug; 209():111096. PubMed ID: 32485478
[TBL] [Abstract][Full Text] [Related]
3. Reactivity and biological properties of a series of cytotoxic PtI2(amine)2 complexes, either cis or trans configured.
Messori L; Cubo L; Gabbiani C; Álvarez-Valdés A; Michelucci E; Pieraccini G; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Casini A; Quiroga AG
Inorg Chem; 2012 Feb; 51(3):1717-26. PubMed ID: 22225466
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
5. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents.
Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M
J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469
[TBL] [Abstract][Full Text] [Related]
6. Improving of Anticancer Activity and Solubility of Cisplatin by Methylglycine and Methyl Amine Ligands Against Human Breast Adenocarcinoma Cell Line.
Shams Abyaneh FS; Eslami Moghadam M; Divsalar A; Ajloo D; Hosaini Sadr M
Appl Biochem Biotechnol; 2018 Oct; 186(2):271-291. PubMed ID: 29516403
[TBL] [Abstract][Full Text] [Related]
7. cis-Pt I2(NH3)2: a reappraisal.
Marzo T; Pillozzi S; Hrabina O; Kasparkova J; Brabec V; Arcangeli A; Bartoli G; Severi M; Lunghi A; Totti F; Gabbiani C; Quiroga AG; Messori L
Dalton Trans; 2015 Sep; 44(33):14896-905. PubMed ID: 26226326
[TBL] [Abstract][Full Text] [Related]
8. Peculiar features in the crystal structure of the adduct formed between cis-PtI2(NH3)2 and hen egg white lysozyme.
Messori L; Marzo T; Gabbiani C; Valdes AA; Quiroga AG; Merlino A
Inorg Chem; 2013 Dec; 52(24):13827-9. PubMed ID: 24256441
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
[TBL] [Abstract][Full Text] [Related]
10. Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.
Pivetta T; Lallai V; Valletta E; Trudu F; Isaia F; Perra D; Pinna E; Pani A
J Inorg Biochem; 2015 Oct; 151():107-14. PubMed ID: 26021964
[TBL] [Abstract][Full Text] [Related]
11. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
[TBL] [Abstract][Full Text] [Related]
12. The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions.
Brabec V; Pracharova J; Novakova O; Gibson D; Kasparkova J
Dalton Trans; 2015 Feb; 44(8):3573-82. PubMed ID: 25406573
[TBL] [Abstract][Full Text] [Related]
13. A complete kinetic study of GG versus AG plantination suggests that the doubly aquated derivatives of cisplatin are the actual DNA binding species.
Legendre F; Bas V; Kozelka J; Chottard JC
Chemistry; 2000 Jun; 6(11):2002-10. PubMed ID: 10894399
[TBL] [Abstract][Full Text] [Related]
14. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
[TBL] [Abstract][Full Text] [Related]
15. G-G base-pairing in nucleobase adducts of the anticancer drug cis-[PtCl2(NH3)(2-picoline)] and its trans isomer.
McGowan G; Parsons S; Sadler PJ
Chemistry; 2005 Jul; 11(15):4396-404. PubMed ID: 15880542
[TBL] [Abstract][Full Text] [Related]
16. Multiple Condensation Reactions Involving Pt(II) /Pd(II) -OH2 , Pt-NH3 , and Cytosine-NH2 Groups: New Twists in Cisplatin-Nucleobase Chemistry.
Yin-Bandur L; Sanz Miguel PJ; Rodríguez-Santiago L; Sodupe M; Berghaus M; Lippert B
Chemistry; 2016 Sep; 22(38):13653-68. PubMed ID: 27516223
[TBL] [Abstract][Full Text] [Related]
17. Internalization of Ineffective Platinum Complex in Nanocapsules Renders It Cytotoxic.
Vrana O; Novohradsky V; Medrikova Z; Burdikova J; Stuchlikova O; Kasparkova J; Brabec V
Chemistry; 2016 Feb; 22(8):2728-35. PubMed ID: 26789279
[TBL] [Abstract][Full Text] [Related]
18. Elusive intermediates in cisplatin reaction with target amino acids: Platinum(II)-cysteine complexes assayed by IR ion spectroscopy and DFT calculations.
Corinti D; Paciotti R; Coletti C; Re N; Chiavarino B; Crestoni ME; Fornarini S
J Inorg Biochem; 2022 Dec; 237():112017. PubMed ID: 36209532
[TBL] [Abstract][Full Text] [Related]
19. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B
Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the membrane interaction of polynuclear platinum anticancer agents. Implications for cellular uptake.
Liu Q; Qu Y; Van Antwerpen R; Farrell N
Biochemistry; 2006 Apr; 45(13):4248-56. PubMed ID: 16566599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
